World COVID-19 Testing Markets Analysis Report 2023: Insurance Coverage, Multiplex Testing, EUAs and Public Health Emergency Expiration, & New Variants On the Horizon - ResearchAndMarkets.com
2023-06-13
诊断试剂
DUBLIN--(BUSINESS WIRE)--The "COVID-19 Testing Markets, 2023" report has been added to ResearchAndMarkets.com's offering.
The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of a wide selection of diagnostic tests in all markets. Diagnostics have been critical in the response to COVID-19.
Some of the key topics and trends explored include:
At-Home Testing
Insurance Coverage
Multiplex Testing
Expiration of Public Health Emergency
New Variants on the Horizon
Immunoassay Testing
Molecular Testing
Competitive Analysis
The report includes an analysis and profiles of key companies competing in this industry, including a breakout of the top competitors in the COVID-19 testing market based on 2022 manufacturer revenues.
Companies profiled include:
Abbott
Becton-Dickinson
Cue Health
Diasorin
Hologic
Seegene
Siemens Healthineers
Scope and Methodology
All market data pertains to the world market at the manufacturers' level. The market includes manufacturer tests. The base year for data was 2022. Data are provided for 2022 and 2027 with compound annual growth rates (CAGRs) for 2022 and 2027.
Competitive analysis is provided for the top ten participants in the market. Regional breakdowns are surveyed for North America, Europe, Asia-Pacific, and the Rest of the World.
The forecasted market analysis through 2027 was largely based on demographic trends, new developments, the trajectory of COVID-19 and its variants, innovative technology and global use.
Key Topics Covered:
Chapter 1: Executive Summary
Industry at a Glance
Scope and Methodology
Size and Growth of the Market
Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales by Segment, 2022-2027
Global COVID-19 Market by Key Segment (Molecular, Immunoassay), 2020-2027
Key Issues and Trends Affecting the Market
Competitive Outlook
Conclusion Highlights
Chapter 2: Introduction
Overview
Coronavirus (COVID-19) 7-Day Case Snapshot Global by Country
Coronavirus (COVID-19) Cumulative Cases and 7-Day Cases by WHO Region (Africa, Americas, Eastern Mediterranean, Europe, South-East Asia, West Pacific)
Country-Level COVID-19 Cumulative Cases Through April 11, 2023
Country-Level COVID-19 Cumulative Diagnostic Tests Administered, by Country Through April 11, 2023
New Cases vs. Total Cases for Select Countries with Uptick in Cases, by Country, April 2023
Chapter 3: Issues and Trends
At-Home Testing
At-Home COVID-19 Test Distribution of Sales, by Vendor (Abbott Diagnostics, Becton Dickinson, OraSure Technologies, Quidel, Siemens Healthineers, Others)
Insurance Coverage
Multiplex Testing
EUAs and Public Health Emergency Expiration
New Variants On the Horizon
Chapter 4: COVID-19 Immunoassay Testing
Overview
Enzyme-linked Immunosorbent Assay (ELISA)
Mass Spectrometry
Rapid
Products
Antigen
Antibody
Market Size and Growth
Competitive Market Share
Immunoassay COVID-19 Vendor Market Share, by Vendor (Abbott, Beckman Coulter-Danaher, Becton Dickson, Diasorin, Fujirebio Diagnostics, PerkinElmer, QuidelOrtho, Roche, Siemens, ThermoFisher, Others), 2022 (%)
Chapter 5: COVID-19 Molecular Testing
Overview
Products
Selected Molecular EUA Tests for COVID-19
Market Size and Growth
Competitive Market Share
Molecular COVID-19 Vendor Market Share, by Vendor (Abbott, bioMerieux, Cepheid-Danaher, Hologic, Orasure Technologies, PerkinElmer, Qiagen, QuidelOrtho, Roche, ThermoFisher, Others), 2022 (%)
Chapter 6: Total COVID-19 Testing Market Summary
Market Overview
Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales, by Segment, 2022-2027 ($MN)
Market Segment by Test Type/Site
Global COVID-19 Testing by Test Site (Laboratory, Rapid/Near Patient) Sales by Segment, 2022-2027
Global COVID-19 IVD Market by Test Site, 2020-2022 and Forecast Through 2027 ($MN)
Laboratory-Based
Global Lab-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN)
Point of Care
Global Rapid-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN)
Global COVID-19 IVD Market by Test Method, 2020-2022 and Forecast Through 2027 ($MN)
Estimated Global COVID-19 Testing Market by Region, 2020-2022
COVID-19 Testing Market by Country, Estimated 2022 ($M)
Competitive Analysis
Top 10 COVID-19 Vendors and Global Market Share, by Vendor (Abbott, bioMerieux, Danaher, Hologic, PerkinElmer, Qiagen, QuidelOrtho, Roche, Siemens, ThermoFisher, Others), 2022
Chapter 7: Selected Market Participants
Beckman Coulter-Danaher
Becton Dickinson
bioMerieux
Cepheid-Danaher
Cue Health
Siemens Healthineers GmbH
For more information about this report visit https://www.researchandmarkets.com/r/wrpavu
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。